Dr Reddy's founder K Anji Reddy dies at 72
- Tanzanian student was not stripped, paraded naked: K'taka Home Minister
- National Herald case: Sonia, Rahul Gandhi move SC challenging Delhi HC order
- Budget session of Parliament to begin on Feb 23; Jaitley hopeful of GST
- Suspended UP chief engineer Yadav Singh arrested, Congress, BJP say probe links
- Will stand by Pakistan if it acts on terror: Rajnath Singh
K Anji Reddy, the founder and Chairman of nation's second-largest drugmaker Dr Reddy's Laboratories Ltd, died today.
Reddy, who founded DRL in 1984, was ailing for some time, a company statement said. He was 72.
He died of liver cancer at 3.45 pm at the Apollo Hospital in Hyderabad.
Many in the industry saw in him a drug discovery pioneer. Dr Reddy set up his R&D facility at what was once his farm.
A chemical engineer who also served as a member on Prime Minister's Council on Trade & Industry, Reddy is survived by wife Samrajyam, daughter Anuradha and son K Satish Reddy, who is the managing director and COO of the company. His son-in-law G V Prasad is the Vice Chairman and CEO of the company.
In April 2011, he was honoured with the Padma Bhushan, one of the highest Civilian Awards in India, recognising his distinguished service of high order in the field of Trade and Industry.
Reddy spearheaded and founded the Neo-natal Intensive Care and Emergencies called 'NICE Foundation', the only institute for new-borns in Asia.
In 1998, Reddy set up Naandi Foundation for proving safe drinking water in rural areas. The foundation gives midday meals to 1.3 million government school-going children and farmers, a DRL statement said.
- Outcome on Section 377 will depend on composition of the Constitution bench
- Inadequate staff, payment delays undermine MGNREGA in drought-hit Mahabubnagar
- ICDS, the primary scheme targeting malnutrition, needs to be broadened
- Rohith's death must focus attention on the rites of exclusion in the university
- Telescope: State in the bedroom
- The economy is best served by lowering interest rates and blocking protectionism